Back
Design Therapeutics Vs. Biogen Industry Stock Comparison
Sell
47
DSGN
Design Therapeutics
Last Price:
5.88
Seasonality Move:
-19.8%
Sell
37
BIIB
Biogen
Last Price:
199.29
Seasonality Move:
9.16%
Sell
47
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy, Sell or Hold?
- The current Design Therapeutics [DSGN] share price is $5.88. The Score for DSGN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- DSGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $199.36. The Score for BIIB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DSGN Stock Price Chart
What is Design Therapeutics's stock price today?
-
The Design Therapeutics share price today is $5.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight selling pressure.
BIIB Stock Price Chart
DSGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 63.14 | Buy |
| Chaikin Money Flow: | -157563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.7 - 5.58) | Buy |
| Bollinger Bands (100): | (3.68 - 5.02) | Buy |
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.43 | Sell |
| Relative Strength Index (14 RSI): | 43.7 | Sell |
| Chaikin Money Flow: | 1538781 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (198.98 - 205.06) | Sell |
| Bollinger Bands (100): | (204.63 - 228.99) | Sell |
DSGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.66 | Buy |
| 20-day SMA: | 5.2 | Buy |
| 50-day SMA: | 4.82 | Buy |
| 200-day SMA: | 3.62 | Buy |
| 8-day EMA: | 5.64 | Buy |
| 20-day EMA: | 5.3 | Buy |
| 50-day EMA: | 4.85 | Buy |
| 200-day EMA: | 4.23 | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 198.55 | Buy |
| 20-day SMA: | 201.38 | Sell |
| 50-day SMA: | 207.79 | Sell |
| 200-day SMA: | 223.53 | Sell |
| 8-day EMA: | 199.4 | Sell |
| 20-day EMA: | 201.12 | Sell |
| 50-day EMA: | 206.76 | Sell |
| 200-day EMA: | 223.03 | Sell |
Design Therapeutics Earnings Growth & DSGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.03 per share, an increase this year of $1.16 per share, and an increase next year of $0.78 per share.
Design Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biogen Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||